Inventor · disambiguated record
Tanweer A. Khan
Also filed as: KHAN TANWEER · KHAN TANWEER A
17 granted patents·18 pending applications·30 citations·filing 2013–2025
90Inventor score
Files withMERCK SHARP & DOHME11ATAI THERAPEUTICS INC10ATAI Life Sciences AG5EMPATHBIO INC4MERCK SHARP & DOHME LLC2
Top patents by PatentIndex Score
35 records- 0196US12065405B2Prodrugs and conjugates of dimethyltryptamineATAI THERAPEUTICS INC·Filed 2023·Granted Aug 20, 2024·4 cites·30 claims
- 0296US11643391B2Prodrugs and conjugates of dimethyltryptamineATAI Life Sciences AG·Filed 2022·Granted May 9, 2023·7 cites·8 claims
- 0394US12012381B2Dimethyltryptamine analogues as nitric oxide delivery drugsATAI THERAPEUTICS INC·Filed 2022·Granted Jun 18, 2024·4 cites·33 claims
- 0494US11912680B2Nitric oxide releasing prodrugs of MDA and MDMAATAI Life Sciences AG·Filed 2022·Granted Feb 27, 2024·3 cites·62 claims
- 0594US11827580B2Aminotetraline activators of serotonin receptorsATAI Life Sciences AG·Filed 2022·Granted Nov 28, 2023·4 cites·58 claims
- 0691US11845736B2Prodrugs of MDMA, MDA, and derivatives thereofEMPATHBIO INC·Filed 2022·Granted Dec 19, 2023·2 cites·25 claims
- 0784US12351537B2Dimethoxyphenylalkylamine activators of serotonin receptorsATAI THERAPEUTICS INC·Filed 2024·Granted Jul 8, 2025·0 cites·11 claims
- 0880US12454516B2Nitric oxide releasing prodrugs of MDA and MDMAEMPATHBIO INC·Filed 2024·Granted Oct 28, 2025·0 cites·62 claims
- 0980US12344570B2Aminotetraline activators of serotonin receptorsATAI THERAPEUTICS INC·Filed 2023·Granted Jul 1, 2025·0 cites·18 claims
- 1079US2025282712A1Dimethoxyphenylalkylamine activators of serotonin receptorsATAI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1178US9422255B2S-imino-S-oxo-iminothiazine compounds as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2014·Granted Aug 23, 2016·2 cites·13 claims
- 1277US10138212B2Aminoquinazoline compounds as A2A antagonistMERCK SHARP & DOHME·Filed 2016·Granted Nov 27, 2018·2 cites·18 claims
- 1376US2025026731A1Prodrugs of mdma, mda, and derivatives thereofEMPATHBIO INC·Filed 2024·Application pending·0 cites
- 1475US2025282708A1Aminotetraline activators of serotonin receptorsATAI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1573US9428476B2S-imino-S-oxo-iminothiadiazine compounds as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2014·Granted Aug 30, 2016·2 cites·13 claims
- 1667US11926574B2Dimethoxyphenylalkylamine activators of serotonin receptorsENTHEOGENIX BIOSCIENCES INC·Filed 2022·Granted Mar 12, 2024·0 cites·21 claims
- 1767US2025152553A1Carbamothioate, and carbamodithioate derivatives of mdma, mda or its optically active (r)- or (s)-mdma and mda isomersEMPATHBIO INC·Filed 2024·Application pending·0 cites
- 1867US2024287107A1Prodrugs of dimethyltryptamine and derivatives thereofATAI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1967US2025197395A1Ibogaine and noribogaine analogs and uses thereofATAI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2066US2024366542A1Sulfoximine activators of serotonin receptorsATAI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2166US2024425470A1Substituted benzofuran propyl amine modulators of monoaminergic transportersATAI Life Sciences AG·Filed 2024·Application pending·0 cites
- 2265US2024376116A1Ibogaine and noribogaine analogs and methods of useATAI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2365US2021379020A1Compounds for the treatment of malariaMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 2463US2024116896A1Heteroatom substituted cyclic and alkyl amines as activators of serotonin receptorsATAI Life Sciences AG·Filed 2023·Application pending·0 cites
- 2557US2019046507A1Compounds for the treatment of malariaMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 2657US2020223220A1Compounds for the treatment of malariaMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 2756US2025136592A1C-linked inhibitors of enl/af9 yeatsBRIDGE MEDICINES·Filed 2022·Application pending·0 cites
- 2852US9156848B2Treating diabetes with dipeptidyl peptidase-IV inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Oct 13, 2015·0 cites·20 claims
- 2951US2023027198A1Inhibitors of enl/af9 yeatsUNIV ROCKEFELLER·Filed 2020·Application pending·0 cites
- 3047US12440496B2Natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetesMERCK SHARP & DOHME LLC·Filed 2020·Granted Oct 14, 2025·0 cites·15 claims
- 3147US2022281886A1Natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetesMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 3245US11766435B2N3-substituted iminopyrimidinones as antimalarial agentsMERCK SHARP & DOHME LLC·Filed 2017·Granted Sep 26, 2023·0 cites·6 claims
- 3345US10696639B2Heterocyclic compounds as HIV protease inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Jun 30, 2020·0 cites·13 claims
- 3439US2020261421A1Heterocyclic compounds as hiv protease inhibitorsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 3538US2020069691A1Heterocyclic compounds as hiv protease inhibitorsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tanweer A. Khan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →